MedTrace Logo

Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women

NCT02706509 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-03-11

No results posted yet for this study

Summary

A multicenter prospective interventional comparative study that investigate pain management during Jaydess insertion in nulliparous women that will be tested by the analgesic affects of oral tramadol or 'verbal anesthesia' on the patients.

Conditions

  • IUD Insertion Complication

Interventions

DRUG

Tramadol

patient will receive oral Tramadol 50 mg an hour before IUD insertion

BEHAVIORAL

Verbal anesthesia

patient will receive full explanation about the procedure for five minutes before IUD insertion

DEVICE

Jaydess

Patient will go through an insertion of Jaydess intrauterine device.

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-09-30
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02706509 on ClinicalTrials.gov